Catatonia
15
3
4
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.7%
1 terminated out of 15 trials
80.0%
-6.5% vs benchmark
7%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (15)
EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
Blood Concentration in Lorazepam and Treatment in Adult Catatonia
Clonidine to Prevent Delirium After Electroconvulsive Therapy.
Catatonic Syndrome in Adult Patients at Basurto Hospital: A Descriptive Study of Incidence, Comorbidity, and Short-Term Outcomes
Optimizing Stimulation Parameters for Electroconvulsive Therapy
Management of Catatonic Features in Adolescents With Profound Autism
Use of MRI and cTBS for Catatonia in Autism
Immunogenomic Analyses of Pediatric Catatonia
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia
Catatonia: Effectiveness of Transcranial Direct Current Electrostimulation (CATATOES)
Improving the Understanding of Catatonia in Autism
Survey on Pre-ECT Evaluation and ECT Application
Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and Cataphasia
Prospective Treatment Study of Catatonia Patients
Catatonia in Nodding Syndrome and Lorazepam Treatment